Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent. Kiran Shroff / Friday, November 29, 2024 / Article rating: 4.0 From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
Pharma stock under Rs 55 in focus as company reports a 38.1 per cent revenue surge & 39.07 per cent jump in PAT Pharma stock under Rs 55 in focus as company reports a 38.1 per cent revenue surge & 39.07 per cent jump in PAT From Rs 43.42 per share (52-week low) to Rs 50.40 per share, the stock is up by 16 per cent. Kiran Shroff / Thursday, November 14, 2024 / Article rating: 4.2 From Rs 43.42 per share (52-week low) to Rs 50.40 per share, the stock is up by 16 per cent.
Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split! Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split! From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years. Kiran Shroff / Friday, August 30, 2024 / Article rating: 4.6 From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.
Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside! Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside! From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years. Kiran Shroff / Tuesday, August 20, 2024 / Article rating: 3.7 From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.
Multibagger pharma stock under Rs 65 to keep under the radar as Board announces cutoff date for final dividend! Multibagger pharma stock under Rs 65 to keep under the radar as Board announces cutoff date for final dividend! From Rs 33.30 per share (52-week low) to Rs 61.25 per share, the stock is up by 84 per cent and gave multibagger returns of 130 per cent in 2 years. I Kiran Shroff / Wednesday, August 14, 2024 / Article rating: 4.7 From Rs 33.30 per share (52-week low) to Rs 61.25 per share, the stock is up by 84 per cent and gave multibagger returns of 130 per cent in 2 years. I
Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25) Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25) From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years. Kiran Shroff / Wednesday, August 7, 2024 / Article rating: 3.7 From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.
10:1 stock split in FY24: Multibagger pharma stock under Rs 70 zooms over 9 per cent in just 1 day with 8 times spurt in volume; Keep under the radar! 10:1 stock split in FY24: Multibagger pharma stock under Rs 70 zooms over 9 per cent in just 1 day with 8 times spurt in volume; Keep under the radar! From Rs 29.32 per share (52-week low) to Rs 65.85 per share, the stock gave multibagger returns of 124.6 per cent. Kiran Shroff / Thursday, July 25, 2024 / Article rating: 3.7 From Rs 29.32 per share (52-week low) to Rs 65.85 per share, the stock gave multibagger returns of 124.6 per cent.
Multibagger pharma stock under Rs 80 & 10:1 stock split in FY24: Company announced stellar FY24 results; PAT zooms over 100 per cent Multibagger pharma stock under Rs 80 & 10:1 stock split in FY24: Company announced stellar FY24 results; PAT zooms over 100 per cent . From Rs 23.3 per share (52-week low) to Rs 75.45 per share, the stock gave multibagger returns of 224 per cent. Kiran Shroff / Monday, May 27, 2024 / Article rating: 3.7 . From Rs 23.3 per share (52-week low) to Rs 75.45 per share, the stock gave multibagger returns of 224 per cent.
10:1 Stock Split: Heavy buying witnessed in this multibagger pharma stock under Rs 75; FIIs bought a 1.97 per cent stake! 10:1 Stock Split: Heavy buying witnessed in this multibagger pharma stock under Rs 75; FIIs bought a 1.97 per cent stake! From Rs 23.16 per share (52-week low) to Rs 70.39 per share, the stock gave multibagger returns of over 200 per cent. Kiran Shroff / Monday, April 22, 2024 / Article rating: 4.0 From Rs 23.16 per share (52-week low) to Rs 70.39 per share, the stock gave multibagger returns of over 200 per cent.
10:1 Stock Split: FIIs bought 27,73,291 shares of this multibagger pharma stock below Rs 75; Board allocated 47,18,080 equity shares to non-promoters via preferential issue! 10:1 Stock Split: FIIs bought 27,73,291 shares of this multibagger pharma stock below Rs 75; Board allocated 47,18,080 equity shares to non-promoters via preferential issue! From Rs 22 per share (52-week low) to Rs 70.17 per share, the stock gave multibagger returns of over 200 per cent. Kiran Shroff / Wednesday, March 6, 2024 / Article rating: 3.9 In December 2023, Foreign Institutional Investors (FIIs) bought 27,73,291 shares of this company and increased their stake to 1.82 per cent from 0.95 per cent in September 2023.